findmyKOL
Clinical trialNCT04943692SuspendedPhase 3Interventional

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes

SponsorLaboratorios Silanes S.A. de C.V.Enrollment500Type 2 Diabetes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Edmundo D Ríos Mejía, M.D

    Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V. (IBIOMED-AGS)

    Principal Investigator
  • Fernando J Lavalle González, M.D

    Servicio de endocrinología Hospital Univertsitario, UANL

    Principal Investigator
  • Francisco G Padilla Padilla, M.D

    Independent

    Principal Investigator
  • Guillermo Fanghänel Salmón, M.D

    Clinica integral del paciente diabético y obeso

    Principal Investigator
  • Joel Rodríguez Saldaña, M.D

    Resultados médicos, desarrollo e investigación SC. (REMEDI)

    Principal Investigator
  • Jorge V Yamamoto Cuevas, M.D

    Clínica Villa Coapa La Vereda S.C.

    Principal Investigator
  • José De la Cruz Tun Pech, M.D

    Mérida Investigación Clínica (Red OSMO)

    Principal Investigator
  • Luis M Román Pintos, M.D

    Hospital Hispanos S.A. de C.V.

    Principal Investigator
  • Manuel González Ortiz, M.D

    Instituto de terapéutica experimental y clínica (INTEC)

    Principal Investigator
  • María L Sánchez Aldana Robles, M.D

    Investigación Biomédica para el Desarrollo de Fármacos, S.A de C.V. (IBIOMED-GDL)

    Principal Investigator
  • Santiago P Ramírez Díaz, M..D

    Centro de Investigación Médica Aguascalientes (Red OSMO)

    Principal Investigator
  • Víctor Bohórquez López, M.D

    Oaxaca Site Management Organization SC. (Red OSMO)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mexico
  • Laboratorio Silanes, S.A. de C.V.

    Mexico City, Mexico

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2021
Primary completion
31 Aug 2021
Completion
31 Aug 2021
Last update posted
29 Jun 2021
Registered enrollment
500
Registry id
NCT04943692

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.